Upjohn Inc Contracts & Agreements

Separation Agreement and Release with Sanjeev Narula, dated December 15, 2023 (Filed With SEC on February 28, 2024)

Separation Agreement and Release with Anthony Mauro, dated October 20, 2023 (Filed With SEC on February 28, 2024)

Retirement and Operating Consulting Agreement and Release with Rajiv Malik, dated October 20, 2023 (Filed With SEC on February 28, 2024)

Offer Letter with Theodora (Doretta) Mistras, dated December 15, 2023 (Filed With SEC on February 28, 2024)

Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 28, 2024)

Omnibus Amendment No. 2, effective as of December 19, 2023, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilars Newco Limited, and Biocon Biologics Limited (Filed With SEC on February 28, 2024)

Transaction Agreement, dated as of January 29, 2024, by and among Cooper Consumer Health SAS, Cooper Consumer Health IT S.r.l., Viatris Inc., Viatris Italia S.r.l. and Ipex AB (Filed With SEC on January 30, 2024)

Transition and Advisory Agreement and Release, dated May 19, 2023, by and between Viatris Inc. and Robert J. Coury (Filed With SEC on August 7, 2023)

Omnibus Amendment No. 1, effective as of May 17, 2023, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilar Collaborations Ireland Limited, Biosimilars Newco... (Filed With SEC on August 7, 2023)

Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 3, 2023 (Filed With SEC on May 8, 2023)

Separation Agreement with Michael Goettler, dated February 24, 2023 (Filed With SEC on February 27, 2023)

Offer Letter with Scott A. Smith, dated February 24, 2023 (Filed With SEC on February 27, 2023)

Amendment No. 1 to Transaction Agreement, dated as of November 28, 2022, by and between Biocon Biologics Limited and Viatris Inc (Filed With SEC on November 29, 2022)

Transaction Agreement, dated as of February 27, 2022, by and among Biocon Biologics Limited and Viatris Inc (Filed With SEC on February 28, 2022)

Amended and Restated Revolving Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders and issuing banks from time... (Filed With SEC on July 1, 2021)

Term Loan Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders from time to time party thereto and Mizuho Bank,... (Filed With SEC on July 1, 2021)

Form of Director Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for non-employee directors for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)

Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)

Form of Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)

Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Rajiv Malik (Filed With SEC on March 1, 2021)

Form of Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan for Michael Goettler and Sanjeev Narula (Filed With SEC on March 1, 2021)

Value Creation Incentive Award Performance-Based Restricted Stock Unit Award Agreement for Robert J. Coury under the Viatris Inc. 2020 Stock Incentive Plan, effective as of... (Filed With SEC on March 1, 2021)

Amendment No. 1, dated as of November 5, 2020, to the Asset Purchase Agreement dated as of September 7, 2020, between Aspen Global Incorporated and Mylan Ireland Limited (Filed With SEC on March 1, 2021)

Letter Agreement entered into on February 6, 2020 by and between Pfizer Inc. and Sanjeev Narula (Filed With SEC on March 1, 2021)

Letter Agreement entered into on June 25, 2019 by and between Pfizer Inc. and Sanjeev Narula (Filed With SEC on March 1, 2021)

Letter Agreement entered into on June 26, 2019 by and between Pfizer Inc. and Michael Goettler (Filed With SEC on March 1, 2021)

Letter Agreement entered into on July 29, 2019 by and between Pfizer Inc. and Michael Goettler (Filed With SEC on March 1, 2021)

Severance Agreement entered into on December 3, 2020 by and between Viatris Inc. and Michael Goettler (Filed With SEC on March 1, 2021)

Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Anthony Mauro (Filed With SEC on March 1, 2021)

Executive Employment Agreement, entered into on November 20, 2020, by and between Viatris Inc. and Robert J. Coury (Filed With SEC on March 1, 2021)

Form of Indemnification Agreement between Viatris Inc. and each of its directors and its executive officers (Filed With SEC on March 1, 2021)

Form of Retention Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan (Filed With SEC on March 1, 2021)

Form of Make-Whole Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan (Filed With SEC on March 1, 2021)

Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 1, 2021)

First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,... (Filed With SEC on November 19, 2020)

First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee,... (Filed With SEC on November 19, 2020)

First Supplemental Indenture dated November 16, 2020, by and among Upjohn Finance B.V., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A.,... (Filed With SEC on November 19, 2020)

First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee,... (Filed With SEC on November 19, 2020)

First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as... (Filed With SEC on November 19, 2020)

Third Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,... (Filed With SEC on November 19, 2020)

Fourth Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,... (Filed With SEC on November 19, 2020)

First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and Citibank, N.A., London Branch, as... (Filed With SEC on November 19, 2020)

Form of Dealer Agreement among Viatris, Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the dealer thereto (Filed With SEC on November 19, 2020)

Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Trademark License Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Intellectual Property Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Manufacturer) and Pfizer Inc. (as Customer) (Filed With SEC on November 19, 2020)

Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Manufacturer) and Upjohn Inc. (as Customer) (Filed With SEC on November 19, 2020)

Employee Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Tax Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Transition Services Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Service Provider) and Pfizer Inc. (as Service Recipient) (Filed With SEC on November 19, 2020)

Transition Services Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Service Provider) and Upjohn Inc. (as Service Recipient) (Filed With SEC on November 19, 2020)

Amendment No. 3 to the Separation and Distribution Agreement, dated as of September 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)

Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 10, 2020)

Indenture, dated as of June 22, 2020, between Upjohn Inc., as issuer, and The Bank of New York Mellon, as trustee (Filed With SEC on June 26, 2020)

Indenture, dated as of June 23, 2020, among Upjohn Finance B.V., as issuer, Upjohn Inc., as guarantor, and Citibank, N.A., London Branch, as trustee, transfer agent, paying agent... (Filed With SEC on June 26, 2020)

Registration Rights Agreement, dated as of June 22, 2020, by and between Upjohn Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan... (Filed With SEC on June 26, 2020)

Delayed Draw Term Loan Credit Agreement, dated as of June 16, 2020, among Upjohn, the guarantors from time to time party thereto, the lenders from time to time party thereto and... (Filed With SEC on June 17, 2020)

Revolving Credit Agreement, dated as of June 16, 2020, among Upjohn, the guarantors from time to time party thereto, the lenders and issuing banks from time to time party thereto... (Filed With SEC on June 17, 2020)

Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on June 2, 2020)

Amendment No. 1, dated as of May 29, 2020, to the Business Combination Agreement, dated as of July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc.,... (Filed With SEC on June 2, 2020)

Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on May 12, 2020)

Category

Industry

Companies

Contracts

Upjohn Inc Contracts & Agreements